Quality of life during the first 6 months of interferon-β treatment in patients with MS
Quality of life during the first 6 months of interferon-β treatment in patients with MS
About this item
Full title
Author / Creator
Publisher
London: Arnold
Journal title
Language
English
Formats
Publication information
Publisher
London: Arnold
Subjects
More information
Scope and Contents
Contents
To determine the quality of life (QoL) of MS patients during the initial 6 months of treatment with interferon-beta (IFN-beta). Furthermore, to determine whether changes in QoL relate to disability, emotional state, therapeutic expectations or side effect profile.
IFN-beta has been shown to have beneficial effects on the course of MS. Since the...
Alternative Titles
Full title
Quality of life during the first 6 months of interferon-β treatment in patients with MS
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72408648
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72408648
Other Identifiers
ISSN
1352-4585
E-ISSN
1477-0970
DOI
10.1191/135245800678827932
